Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM

Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.
Latest website image capture
Clouds background image

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision history updated: added version v3.5.0 and removed version v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-25T19:56:58.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added, replacing v3.4.2 in the record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:41:09.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and notices including 'Notice Because of a lapse in government funding...' and 'Revision: v3.4.1' were removed from the history; the rest of the study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T04:42:36.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added a site-wide funding notice banner and the revision tag Revision: v3.4.1; removed the previous Revision: v3.4.0 tag.
    Difference
    0.7%
    Check dated 2026-02-04T03:27:19.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page adds a glossary display option and uses green/red highlights to show additions and deletions; there are small textual tweaks such as capitalization of the No FEAR Act data label and the revision tag updated to v3.4.0.
    Difference
    0.8%
    Check dated 2026-01-28T00:36:00.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The screenshot shows Revision: v3.3.4 added and Revision: v3.3.3 removed, indicating a minor UI/version update with no changes to study details.
    Difference
    0.1%
    Check dated 2026-01-14T01:01:23.000Z thumbnail image

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM

Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.